Macro Capital Uses EGP 282 Million to Clear Loans and Credit Facilities

Macro Group for Pharmaceuticals–Macro Capital used EGP 282 million to repay loans and credit facilities, bringing those debts to zero.

The company disclosed the repayment as part of an update on how it used proceeds from the subscription to its capital increase.

The update covered the period through June 30, 2026, providing a snapshot of the use of the funds at the end of that financial reporting period.

The repayment directed capital raised from shareholders toward clearing borrowing obligations. The available summary did not provide a breakdown of other uses of the subscription proceeds.